SCHEMBL2013196

SCHEMBL2013196

Cc1nccc(C(=O)N(C)C(CCNC(=O)c2nc3ccccc3n2C)Cc2ccccc2)n1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.42
HCRTR2 O43614 2/20 0.42
SMN1; SMN2 Q16637 3/20 0.39
TSHR P16473 1/20 0.39
PDE10A Q9Y233 1/20 0.37
RECQL P46063 2/20 0.37
MAPT P10636 2/20 0.36
ALDH1A1 P00352 1/20 0.36
NPC1 O15118 1/20 0.36
TP53 P04637 1/20 0.36
HPGD P15428 1/20 0.36
RAB9A P51151 1/20 0.36
GAA P10253 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2012684 0.90 HCRTR1 (0.42) HCRTR1HCRTR2SMN1; SMN2TSHRPDE10A
SCHEMBL13138972 0.87 HCRTR1 (0.50) HCRTR1HCRTR2SMN1; SMN2TSHRPDE10A
SCHEMBL2014285 0.84 EPHX2 (0.45) HCRTR1HCRTR2SMN1; SMN2
SCHEMBL13138950 0.82 HCRTR1 (0.43) HCRTR1HCRTR2SMN1; SMN2TSHRPDE10A
SCHEMBL13138975 0.82 HCRTR1 (0.50) HCRTR1HCRTR2SMN1; SMN2TSHRRECQL
SCHEMBL2014681 0.81 HCRTR1 (0.43) HCRTR1HCRTR2SMN1; SMN2MAPTALDH1A1
SCHEMBL2014812 0.81 HCRTR1 (0.43) HCRTR1HCRTR2SMN1; SMN2MAPTALDH1A1
SCHEMBL13139051 0.81 HCRTR1 (0.47) HCRTR1HCRTR2SMN1; SMN2PDE10AMAPT
SCHEMBL13139073 0.81 HCRTR1 (0.53) HCRTR1HCRTR2SMN1; SMN2RECQLMAPT
SCHEMBL2015167 0.80 HCRTR1 (0.40) HCRTR1HCRTR2SMN1; SMN2TSHRRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed